Complete pain relief after bevacizumab in a patient with neurofibromatosis type 2

Acta Oncol. 2015 Feb;54(2):280-3. doi: 10.3109/0284186X.2014.956185. Epub 2014 Sep 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Back Pain / drug therapy
  • Bevacizumab
  • Female
  • Humans
  • Lumbosacral Region
  • Neoplasms, Multiple Primary / drug therapy*
  • Neurofibromatosis 2 / drug therapy*
  • Pain / drug therapy*
  • Young Adult

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab